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Abstract 
Objectives: To evaluate a modified Global Trigger Tool (GTT) method with manual review of 
automatic triggered records to measure adverse events.  
 
Design: A cross-sectional study was performed using the original GTT method as gold 
standard compared to a modified GTT method. 
 
Setting: Medium size hospital trust in Northern Norway. 
 
Participants: 1233 records selected between March and December, 2013.  
 
Main outcome measure: Records with triggers, adverse events and number of adverse events 
identified. Recall (sensitivity), precision (positive predictive value), specificity and Cohen’s 
kappa with 95 % confidence interval were calculated. 
 
Results: Both methods identified 35 adverse events per 1000 patient days. The modified GTT 
method with manual review of 658 automatic triggered records identified adverse events 
(n=214) in 189 records and the original GTT method identified adverse events (n=216) in 186 
records. 110 identical records where identified with adverse events by both methods. Recall, 
precision, specificity and reliability for records identified with adverse events were 
respectively 0.59, 0.58, 0.92 and 0.51 for the modified GTT method. The total manual review 
time in the modified GTT method was 23 hours while the manual review time using the 
original GTT method was 411 hours. 
 
Conclusions: The modified GTT method is as good as the original GTT method that complies 
with the GTTs aim monitoring the rate of adverse events. Resources saved by using the 
modified GTT method enable for increasing the sample size. The automatic trigger 
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Introduction 
Identifying and measuring adverse events is important as they entail substantial burden to 
patients and health providers [1]. In addition, the economic burden of adverse events is 
considerable [2]. Adverse events have commonly been identified through voluntary incident 
reporting but this approach significantly underestimates the actual number of adverse events 
as it relies on health care providers willingness and opportunity to report [3]. Hence, trigger 
tools, first described by Jicks [4] and refined by Classen et al [5], were developed to identify 
and measure adverse events. Patient records are screened for specific elements (triggers) in 
the records. Once a trigger is identified a more in-depth review is performed to determine if 
an adverse event may have occurred [6]. The trigger search is performed in randomly selected 
records, usually a limited number that is manageable [7]. The Institute for Healthcare 
Improvement (IHI) refined the trigger tools further and developed the Global Trigger Tool 
(GTT) which has successfully been advocated with the aim to monitor adverse events in adult 
inpatients [8]. The GTT is an easy two-step method of retrospective manual review of record 
samples: Two primary reviewers (nurses) individually review the records for  specific triggers 
and determine if the triggers represent any adverse events, before reaching consensus (step 1). 
A secondary reviewer (physician) authenticates their findings (step 2) [8]. In Norway all 
hospitals are instructed by the commissioning documents from the ministry of health to 
perform the GTT [9]. 
 
Many have considered the GTT as the best method to identify and measure adverse events. 
Results from the GTT demonstrates that one of five hospitalized patients experience at least 
one adverse event [10]–[12]. However, the practical disadvantages of the GTT, being 
resource-intensive due to time and personnel required, limits widespread use and adoption. 
Automatic identification of triggers in electronic health records (EHRs) provides a digital, 
standardized and cost-effective approach to measure adverse events [13]. Rather than a 
reviewer searches for triggers, algorithms are written to automatically identify triggers. The 
benefits are promising, ones the algorithms are written, as manual review is only performed in 
the automatic triggered records [14]–[16]. However, the validity of automatic systems in 
comparison to other methods measuring adverse events varies [12]–[14].  
 
We developed an automatic trigger identification system that identifies 42 of the GTT 
triggers. We included the system in a modified GTT method where manual review to identify 
adverse events was limited to only automatic triggered records, illustrated in figure 1. We 
considered the original GTT method with all manual review steps as the gold standard. This 
study aimed to evaluate the modified GTT methods ability to identify and measure adverse 




The study is an explorative cross-sectional study comparing a modified GTT method to the 
original GTT method to identify and measure adverse events.  
 
Setting 
The study was performed at a 524-bed trust with three hospitals in Nordland County, 
Northern Norway. The trust has approximately 14,000 discharges and 90,000 patients days 
per year in the somatic adult wards. EHRs (DIPS®, ASA) were implemented in the trust in 
1992. The EHRs includes both free text (i.e.: discharge summaries, operative reports, 
pathology reports, radiology results, transfer of service notes, admission notes, medical 
progress notes and notes from other healthcare professionals) and indexed variables (i.e.: 
laboratory results, admissions and discharge data, diagnosis and procedure codes). In 
Norwegian hospitals medication administration, prescriber orders and recording of vital 
parameters are still hand-written and scanned into the EHRs but are being digitalized and 
indexed within the next two years in clinical information systems. The trust implemented the 
GTT in 2010 with bi-weekly review of 70 records randomly selected from the seven main 
units discharge lists [17].  
 
Participants 
The records included in the study were original selected for the trusts GTT review in the 
period March 1 to December 31, 2013. Patient records were excluded if the patient was 
admitted for less than 24 hours, discharged from psychiatric or rehabilitation units, and was 
aged 17 years or younger, as the triggers were not developed for these patients [8]. Approval 
for the study was obtained from the Data Protection Official in Nordland Hospital trust and by 
the Regional Committee for Medical and Health Research Ethics (ref 2012/1691). The 
committee approved a waiver for informed consent as the study fulfilled criteria described by 
Baker et al [18].   
 
Definition of triggers 
The Norwegian translation of the GTT includes 57 triggers (supplementary file A) [19]. The 
triggers are events recorded in the clinical data such as; abnormal lab values, readmission 
within 30 days, return to surgery, blood transfusion or administration of drugs such as anti-dot 
or anti-emetic drugs [8]. Some of the triggers are adverse events by its nature, for example 
3rd- or 4rd-degree perianal lacerations, pressure ulcer and injury, repair, or removal of organ 
because of accidental injury. However, most of them are just indicators that an adverse event 
may have occurred. A more in-depth review is necessary to decide if the triggers are 
associated with any adverse events.  
 
Definition of an adverse event 
The definition of an adverse event adopted from the GTT was used by both methods when 
deciding if an adverse event was present when performing manual review of the triggered 
records [8]: “Unintended physical injury resulting from or contributed to by medical care that 
requires additional monitoring, treatment or hospitalization, or that results in death”.  
 
The adverse events were categorized according to severity with the adapted definitions from 
the National Coordinating Council for Medication Error Reporting and Prevention Index 
(NCC MERP) for categories E-I [20]:  
Category E: Temporary harm to the patient and required intervention  
Category F: Temporary harm to the patient and required initial or prolonged hospitalisation  
Category G: Permanent patient harm  
Category H: Intervention required to sustain life  
Category I: Patient death 
 
Review methods 
The original GTT method 
Two primary reviewers (nurses) reviewed the records individually in a specific order to 
register any presence of triggers. Once a trigger was identified, a more in-depth review was 
performed to investigate if the trigger was associated with an adverse event according to the 
described definition, all performed within a 20-minute time limit. A secondary reviewer 
(physician) authenticated the primary reviewers’ findings. There was no time constraint for 
the secondary reviewer. Griffin et al estimated that the secondary reviewer uses two hours per 
20 records, confirming or deleting adverse events identified by the primary reviewers [8]. The 
secondary reviewer reviewed only the relevant parts of the records identified with adverse 
events.     
 
The modified GTT method 
The automatic trigger identification system can only identify triggers, not adverse events. The 
system identifies triggers based on algorithms. We have included examples used in such 
algorithms in supplementary file B. The algorithms for indexed variables (e.g., INR> 6, 
glucose< 2.8 or diagnoses/procedures codes) are based on queries. Algorithms for free text 
(e.g., patient fall, specialty obstetric consult, induced labour) are based on information 
extractions and recognitions of text strings and patterns through text mining analysis. All 
conditions and words representing the actual trigger (e.g., patient fell out of bed, patient 
slipped in the bathroom) are extracted. In addition, the system omits the information if 
exclusion criteria are met (e.g., the anastomosis fell in place, the catheter fell out). The 
automatic trigger identification system included 42 triggers used in the Norwegian GTT (see 
supplementary file A). Nine triggers were excluded as the information for these triggers are 
hand written and scanned into the EHR. The automatic trigger identification system cannot 
identify these triggers; use of anti-dot drugs, use of anti-emetic drugs, vitamin K 
administration, hypotension and abrupt medication stop. The three triggers labelled “other” 
related to respectively medication, general and surgical care were not included in the system, 
as they do not correspond to a specific adverse event but used when reviewers identify an 
adverse event without finding a corresponding trigger. Finally, we opted to exclude three 
triggers rarely identified in our previous manual review of 6720 records from 2010 to 2013.  
 
The records, both triggered and non-triggered, were presented in an interface along with 
information regarding triggers identified (e.g.; type of trigger and which note/lab 
test/radiology or pathology report the triggers are detected in). One physician performed 
manual review of the triggered records to decide if the triggers were associated with any 
adverse events and if so, theirs severity and type. The described definition of an adverse event 




1400 records from the trusts GTT review of a 10-month period were selected. 167 records 
were excluded as the data from the automatic trigger identification system was missing for 
these records, leaving a total of 1233 records included in the study. 
 
The objective of this study was to evaluate the modified GTT method. Paired t-test was used 
to compare the number of triggered records, number of records with identified adverse events 
and number of identified adverse events between the methods. A p value < 0.05 was regarded 
significant. We calculated recall (sensitivity), precision (positive predictive value) and 
specificity with their respective 95 % confidence intervals (CI) to evaluate the validity of the 
modified GTT method using the original GTT method as gold standard: 
 
𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅 =
𝑁𝑁𝑁𝑁. 𝑁𝑁𝑜𝑜 𝑅𝑅𝑁𝑁𝑐𝑐𝑐𝑐𝑅𝑅𝑅𝑅𝑐𝑐 𝑝𝑝𝑁𝑁𝑝𝑝𝑝𝑝𝑐𝑐𝑝𝑝𝑝𝑝𝑅𝑅 𝑐𝑐𝑅𝑅𝑅𝑅𝑁𝑁𝑐𝑐𝑟𝑟𝑝𝑝 𝑝𝑝𝑟𝑟𝑅𝑅𝑛𝑛𝑐𝑐𝑝𝑝𝑜𝑜𝑝𝑝𝑅𝑅𝑟𝑟 𝑏𝑏𝑏𝑏 𝑐𝑐ℎ𝑅𝑅 𝑚𝑚𝑁𝑁𝑟𝑟𝑝𝑝𝑜𝑜𝑝𝑝𝑅𝑅𝑟𝑟 𝐺𝐺𝐺𝐺𝐺𝐺 𝑚𝑚𝑅𝑅𝑐𝑐ℎ𝑁𝑁𝑟𝑟




𝑁𝑁𝑁𝑁. 𝑁𝑁𝑜𝑜 𝑅𝑅𝑁𝑁𝑐𝑐𝑐𝑐𝑅𝑅𝑅𝑅𝑐𝑐 𝑝𝑝𝑁𝑁𝑝𝑝𝑝𝑝𝑐𝑐𝑝𝑝𝑝𝑝𝑅𝑅 𝑐𝑐𝑅𝑅𝑅𝑅𝑁𝑁𝑐𝑐𝑟𝑟𝑝𝑝 𝑝𝑝𝑟𝑟𝑅𝑅𝑛𝑛𝑐𝑐𝑝𝑝𝑜𝑜𝑝𝑝𝑅𝑅𝑟𝑟 𝑏𝑏𝑏𝑏 𝑐𝑐ℎ𝑅𝑅 𝑚𝑚𝑁𝑁𝑟𝑟𝑝𝑝𝑜𝑜𝑝𝑝𝑅𝑅𝑟𝑟 𝐺𝐺𝐺𝐺𝐺𝐺 𝑚𝑚𝑅𝑅𝑐𝑐ℎ𝑁𝑁𝑟𝑟




𝑁𝑁𝑁𝑁. 𝑁𝑁𝑜𝑜 𝑅𝑅𝑁𝑁𝑐𝑐𝑐𝑐𝑅𝑅𝑅𝑅𝑐𝑐 𝑛𝑛𝑅𝑅𝑔𝑔𝑅𝑅𝑐𝑐𝑝𝑝𝑝𝑝𝑅𝑅 𝑐𝑐𝑅𝑅𝑅𝑅𝑁𝑁𝑐𝑐𝑟𝑟𝑝𝑝 𝑝𝑝𝑟𝑟𝑅𝑅𝑛𝑛𝑐𝑐𝑝𝑝𝑜𝑜𝑝𝑝𝑅𝑅𝑟𝑟 𝑏𝑏𝑏𝑏 𝑐𝑐ℎ𝑅𝑅 𝑚𝑚𝑁𝑁𝑟𝑟𝑝𝑝𝑜𝑜𝑝𝑝𝑅𝑅𝑟𝑟 𝐺𝐺𝐺𝐺𝐺𝐺 𝑚𝑚𝑅𝑅𝑐𝑐ℎ𝑁𝑁𝑟𝑟
𝑁𝑁𝑁𝑁. 𝑁𝑁𝑜𝑜 𝑛𝑛𝑅𝑅𝑔𝑔𝑅𝑅𝑐𝑐𝑝𝑝𝑝𝑝𝑅𝑅 𝑐𝑐𝑅𝑅𝑅𝑅𝑁𝑁𝑐𝑐𝑟𝑟𝑝𝑝 𝑝𝑝𝑟𝑟𝑅𝑅𝑛𝑛𝑐𝑐𝑝𝑝𝑜𝑜𝑝𝑝𝑅𝑅𝑟𝑟 𝑏𝑏𝑏𝑏 𝑔𝑔𝑁𝑁𝑅𝑅𝑟𝑟 𝑝𝑝𝑐𝑐𝑅𝑅𝑛𝑛𝑟𝑟𝑅𝑅𝑐𝑐𝑟𝑟
 
 
Recall represents the proportion of “correctly” identified records with adverse events by the 
modified GTT method. Precision represents the proportion of records with adverse events 
identified by the modified GTT method that also were identified by the original GTT method. 
Specificity represents the proportion of “correctly” identified records with no identified 
adverse events by the modified GTT method. For reliability, we used Cohen’s Kappa to 
measure agreement of the results (inter-rater reliability) between the methods, taking into 
account the agreement occurring by chance. The following interpretations from Landis and 
Koch were used for the Cohen’s Kappa coefficient: poor (<0.0), slight (0.00–0.20), fair (0.21–
0.40), moderate (0.41– 0.60), substantial (0.61–0.80) and almost perfect (0.81–1.00) [21]. A 
95 % CI was set. The CI for recall, precision, specificity was calculated using the Wilson 
score method [22]. CI for Cohen’s kappa was κ±1.96*SE. All analyses were performed using 
SPSS (version 22.0; SPSS Chicago, IL). 
 
Results 
58 % (716) were women and average age was 58 years (range; 18-102, standard deviation 
(SD); 22). Mean length of stay was 5 days (range; 1-65, SD; 6). 
 
The modified GTT method identified a total of 1216 triggers in 658 records while the original 
GTT method identified a total of 1267 triggers in 626 records. The number of the individually 
triggers identified by each method are included in supplementary file C. In 110 identical 
records, both methods identified adverse events. In 79 records, the modified GTT method 
identified adverse events alone and vice versa in 76 records (figure 2). The recall, precision, 
specificity and Cohen’s kappa with their respective 95 % CI of the modified GTT method are 
presented in table1. Figure 3 displays the types of adverse events identified by the two 
methods which differed between the methods. Number of records identified with adverse 
events and number of identified adverse events according to severity are presented in table 2. 
 
The modified GTT method identified 34.7 adverse events (n=214) per 1000 patient days by 
manual review of 658 automatic triggered records for the 10-month period. Adverse events 
were identified in 28.7 % (n=189 records) of the automatic triggered records (n=658 record). 
Mean manual review time used per record was 2 minutes (range 0.2- 21.5) and the total 
manual review time was 23 hours. The original GTT method identified 35.0 adverse events 
(n=216) per 1000 patient days of 626 manual triggered records in the same 10-month period. 
Adverse events were identified in 15.1 % (n=186 records) of the records reviewed manually 
for triggers and adverse events (n=1233 records). Total manual review time of 1233 records 
was 411 hours. 
 
Discussion 
The aim of this study was to evaluate a modified GTT method with automatic trigger 
identification to identify and measure adverse events using the original GTT method as gold 
standard. We found that the modified GTT method is a valid, reliable and efficient method to 
monitor the rate of adverse events. The modified GTT method demonstrated major decrease 
in review time compared to the original GTT method. Both methods identified a rate of 35 
adverse events per 1000 patient days. There was no significant difference between the 
methods regarding the severity of the identified adverse events. The modified GTT method 
comply with the GTTs aim to monitor the rate of adverse events over time consistently, but 
not completely. 
 
The values of a “new” measure are related to values from a reference measure performed at 
the same time and are defined as the concurrent validity of the measure. Concurrent validity is 
evaluated by recall (sensitivity), precision (positive predictive value) and specificity, which 
we calculated for the modified GTT method. A review of current literature did not find any 
reference to evaluation of the validity of the GTT [23] but studies have demonstrated that the 
GTT identifies more adverse events than other methods [10], [11]. The purpose of the GTT is, 
with an easy method, to select those patients that may have experienced an adverse event by 
the use of triggers as screening criteria. We adopted this purpose when we evaluated the 
modified GTT method. We recorded therefore only the unique number of identified triggers 
in the triggered records and did not considered excessive testing of the individually triggers as 
this was beyond the scope of the study.  
 
The modified GTT method demonstrated an efficient method to identify and measure adverse 
events with a total of 23 hours to complete the manual review of 658 automatic triggered 
records compared to 411 hours of review of 1233 records with the original GTT method. The 
modified GTT method reviewed only the triggered records thereby reducing the number of 
records to be manual reviewed by 50 %. This reduction enables for increasing the sample size 
without applying further resources. Critics have argued that the recommend sample size, 10 
records bi-weekly, in the GTT is too low to estimate the rate of adverse events for an 
institution. Thus, sampling size should correspond to the hospital size [17]. Extrapolation, 
which is used when estimates are made on small samples, increases the random variability. 
Infrequent adverse events can also be missed when only samples of records are reviewed [24]. 
Increasing the sample size makes the results regarding the rate of adverse events more valid 
[17], [25].  
 
The manual review processes differed somewhat between the two methods. Only one 
reviewer, a physician, performed the subsequent manual review of automatic triggered 
records in the modified GTT method. The original GTT method included two primary 
reviewers and a secondary reviewer authenticating their consensus findings. Reviewers in 
both methods were experienced reviewers of the GTT. The aim of the study was to assess if 
the rate of adverse events altered when we modified the GTT with manual review of only 
automatic triggered records. Hence, we do not consider the differences of the manual review 
processes as a bias.  
 
Poor to moderate agreement between reviewers and between review teams have been 
demonstrated [26], [27].We believe the agreement can be improved by using an automatic 
trigger identification system. First, automatic identification of triggers in the EHR excludes 
the variability of manual identified triggers as triggers based on index information (i.e.; blood 
transfusion and dialysis) have demonstrated higher agreement than triggers derived from free 
text (i.e.; pressure ulcers, patient fall) [28]. Second, the manual trigger identification could 
suffer from the time constraints excluding possible triggers causing adverse events to be 
missed [27], [29]. Automatic trigger identification does not have a time constraint and all 
present triggers are identified. These issues make the identified adverse events based on 
automatic trigger identification more standardized and comparable than adverse events 
identified by manual trigger identification. Moreover, with further development, the automatic 
trigger identification system can provide a platform to identify patients at risk of adverse 
events in real-time. Such systems could be used to improve clinical outcome, optimize 
treatment, reduce the financial burden of patient harm and most importantly; reduce the 
suffering of the patients due to adverse events  [24], [30]. However, the development of such 
methods requires both technical and economic inputs.  
 
Strength and limitations 
The main strength of the study is that we demonstrated a valid and efficient method to 
identify and measure adverse events.  
 
Our study has some limitations. First, fifteen of the original 57 triggers were excluded in our 
automatic trigger identification system, but nine of them can be included when all patient data 
are digitalized and indexed in clinical information systems. Second, record reviews depend on 
that the necessary data are documented in the EHR. Records could be incomplete regarding 
documentation of adverse events causing adverse events to be missed. Third, this study has 
been performed in one hospital only. Modification of the automatic trigger identification 
system must be applied before adoption. 
 
Conclusions 
Our study demonstrated that the modified GTT method with automatic trigger identification is 
a valid, reliable and efficient method to identify and measure adverse events to comply the 
aim of the GTT in respect to the original GTT method. We therefore recommend that the 
modified GTT method should be preferred as it offers an efficient alternative to the common 
costly and time-consuming approaches mainly used to identify and measure adverse events. 
The resources saved by using the modified GTT method are considerable and this enables for 
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iRecall represent the proportion of “correctly” records identified with triggers or adverse 
events by the modified GTT method. 
ii95 % confidence interval (CI). 
iiiPrecision represent the proportion of records with triggers or adverse events that were 
confirmed by the original GTT method. 
ivSpecificity represents the proportion of “correctly” records with no identified adverse events 
by the modified GTT method. 
vCohen’s Kappa is the inter-rater reliability of the modified GTT method and the original 
GTT method evaluated by a 2 x 2 table. 
 
  
Table 1 Validity and reliability of the modified GTT method versus the original GTT method (gold standard) 
Variable Recalli (CI)ii Precisioniii (CI)ii  Specificityiv (CI)ii Cohen’s Kappav (CI)ii 
Triggered records 0.83 (0.80-0.86) 0.79 (0.76-0.82) 0.78 (0.74-0.81) 0.61 (0.56-0.66) 
Records with adverse 
events 
0.59 (0.52-0.66) 0.58 (0.51-0.65) 0.92 (0.91-0.94) 0.51 (0.44-0.57) 
Records with adverse 
events within the 
common triggered 
records 




Table 2 Number of adverse events and records with adverse events according to severity identified by the modified 





Original GTT method Modified GTT method 
Records with adverse 
events: 
Modified GTT method 
vs. 
Original GTT method 
Number of adverse 
events: 
Modified GTT method 
vs 















value CI 95% 
E 120 109 95 90 0.08 -0.032-0-002 0.045 -0.04-0.00 
F 87 80 97 91 0.29 -0.008-0.026 0.38 -0.01-0.03 
G 5 5 12 12 0.09 -0.001-0.012 0.09 -0.001-0.01 
H 1 1 1 1 1.00 -0.002-0.002 1.00 -0.002-0.002 
I 3 3 9 9 0.03 0.000-0-009 0.03 0.00-0.01 
Total 216 198*** 214 203** 0.81 0.01- -0.02 0.90 -0.03-0.024 
Notes: Severity level according to the NCC MERP index 
*P-value of Paired sample T-test 
**14 admissions with two more adverse events with different severity level 
***12 admissions with two or more adverse events with different severity level 
Figure 1: The modified GTT method 
Figure 2: Records identified with triggers and adverse events by the modified GTT method 
and the original GTT method 









Figure 2  
Records with adverse 
events identified by both 
methods, n=110 
Records with adverse 
events identified by the 
modified GTT method, 
n=189 
Records with adverse 
events identified by the 













































Adverse events in general care: allergy, bleeding, patient fall, fracture, medical technical 
event, thrombosis/embolism, deterioration of chronic disease and other events.  
 
Adverse surgical events: infection after surgery, return to surgery, injury or removal of an 
organ by accident, bleeding after surgery, respiratory complication after surgery, switch in 
surgery and any other surgical complication.  
 
Hospital acquired infection: urinary tract infection, lower respiratory infection, ventilator-
associated infection, central vein catheter associated infection and other infections.  
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